<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Article Authoring DTD v1.4 20240229//EN" "JATS-articleauthoring1.dtd">
<article article-type="research-article" xml:lang="zh-CN" xmlns:xlink="http://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">12</journal-id>
      <journal-title-group>
        <journal-title>国际医学</journal-title>
        <abbrev-journal-title>International medicine</abbrev-journal-title>
      </journal-title-group>
      <issn>ISSN：3104-4891（Print）（原2972-4163）</issn>
      <publisher>
        <publisher-name>华文科学出版社（HUAWEN SCIENCE PRESS）</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.12421/gjyx202306008</article-id>
      <article-id pub-id-type="publisher-id">396</article-id>
      <title-group>
        <article-title>瑞巴派特片联合艾司奥美拉唑镁肠溶片治疗胃溃疡患者的临床疗效</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <string-name>徐帆 (济宁市第一人民医院）</string-name>
        </contrib>
      </contrib-group>
      <pub-date pub-type="epub">
        <year>2023</year>
        <month>6</month>
      </pub-date>
      <issue>6</issue>
      <abstract>
        <p>摘要：目的：探讨胃溃疡治疗方案，以瑞巴派特片和艾司奥美拉唑药物为研究方向。方法：将 110 例胃溃疡患者分成对照、研究组，对照组单独给予艾司奥美拉唑镁肠溶片治疗，研究组联合瑞巴派特片治疗，比较疗效。结果：和对照组数据相比，研究组胃肠激素、炎性因子及血清学指标改善效果较高，临床症状评分及不良反应发生率较低，P</p>
      </abstract>
    </article-meta>
  </front>
</article>
